Study of the use of gel dosimetry in combination with 3D printing phantom for personalized pretreatment QA in radiotherapy

Abstract

In modern radiotherapy, pretreatment patient-specific quality assurance (PSQA) generally consists in delivering the treatment plan to a phantom equipped with a detector and in comparing the measured dose and the dose calculated by the treatment planning system (TPS) in order to detect any gap between both dose distributions. Dosimetric gels have interesting properties for QA. In this work, the use of gel dosimetry together with a patient-based 3D printed phantom for personalized PSQA is investigated. CT images of a patient with a right mesencephalic brain tumor were used to generate a 3D printed phantom. Then it was filled with water and a radiochromic gel jar and irradiated according to the patient intracranial stereotactic plan using a Novalis TrueBeam STX accelerator. Measured dose distributions agree well with the calculated ones. Regarding 3D gamma-index (1 mm – 2%) estimated within the central 85% of the jar volume, 96.3% of points pass the test. In addition, 86.5% of the points pass the local 2D 3 mm-3% gamma-index. Results are promising but further work is needed to improve the protocol and investigate the possibility to extend it to end-to-end tests.